Esophageal Diseases  >>  gemcitabine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
gemcitabine / Generic mfg.
NCT00012363: S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Completed
2
61
US
gemcitabine hydrochloride, Gemzar (NSC-613327), irinotecan hydrochloride, CPT-11 (NSC-616348)
Southwest Oncology Group, National Cancer Institute (NCI)
Esophageal Cancer, Gastric Cancer
04/06
04/06
NCT01469598: Study of Docetaxel and Gemcitabine in Metastatic Esophageal Squamous Cell Cancer

Completed
2
24
RoW
Gemcitabine/Docetaxel
Samsung Medical Center
Metastatic Carcinoma, Recurrent Esophageal Squamous Cell Carcinoma
02/14
01/15

Download Options